Chemours (CC) PT Lowered to $14 at RBC Capital
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $15.26 +0.59%
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 9
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 9
Join SI Premium – FREE
RBC Capital analyst Arun Viswanathan lowered the price target on Chemours (NYSE: CC) to $14.00 (from $17.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Chemours (CC) PT Lowered to $15 at JPMorgan
- Vinati Organics Ltd (VO:IN) PT Lowered to INR1,170 at Kotak
- Apollo Hospitals (APLH:IN) PT Raised to INR10,025 at Kotak
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
